Jazz Pharmaceuticals (JAZZ) Inventory (2010 - 2026)

Jazz Pharmaceuticals' Inventory history runs 17 years deep, the most recent figure standing at $437.5 million for Q1 2026.

• In Q1 2026, Inventory fell 11.22% year-over-year to $437.5 million; the TTM figure through Mar 2026 stood at $437.5 million (down 11.22% YoY), while the FY2025 annual figure was $417.0 million, down 13.21% from the prior year.
• Inventory for Q1 2026 stood at $437.5 million, up from $417.0 million in the prior quarter.
• The five-year high for Inventory was $985.5 million in Q1 2022, with the low at $417.0 million in Q4 2025.
• The 5-year median for Inventory is $577.3 million (2024), against an average of $606.2 million.
• Peak annual rise in Inventory reached 753.39% in 2022, while the deepest fall reached 36.01% in 2022.
• Jazz Pharmaceuticals' Inventory stood at $714.1 million in 2022, then slipped by 16.39% to $597.0 million in 2023, then decreased by 19.53% to $480.4 million in 2024, then slipped by 13.21% to $417.0 million in 2025, then advanced by 4.92% to $437.5 million in 2026.
• Business Quant data shows JAZZ's Inventory at $437.5 million in Q1 2026, $417.0 million in Q4 2025, and $483.1 million in Q3 2025.